|
Joseph Biederman, MD
Chairperson
Chief, Clinical and Research Program in Pediatric Psychopharmacology,
Massachusetts General Hospital
Professor of Psychiatry Harvard Medical School
An expanded version of this slide presentation was initially developed at an editorial board meeting held on June 22, 2006 in Boston, MA and used at visiting faculty meetings through the year. The faculty who assisted in the core set of slide were:
Peter S. Jensen, MD
Director, Center for the Advancement of Children’s Mental Health
Ruane Professor of Child Psychiatry
Columbia University College of Physicians & Surgeons
James McCracken, MD
Professor of Child Psychiatry
Director, Division of Child and Adolescent Psychiatry
UCLA Neuropsychiatric Institute
Thomas Spencer, MD
Assistant Director of Clinical & Research Program in Pediatric Psychopharmacology
Massachusetts General Hospital
Associate Professor of Psychiatry Harvard Medical School
Timothy Wilens, MD
Associate Professor of Psychiatry Harvard Medical School
Pediatric & Adult Psychopharmacology Clinics
Massachusetts General Hospital
Biographies
Joseph Biederman, MD
Chief, Clinical and Research Program in Pediatric Psychopharmacology
Massachusetts General Hospital
Professor Psychiatry, Harvard Medical School
Dr Biederman is Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at the Massachusetts General Hospital, and Professor of Psychiatry at the Harvard Medical School. Dr Biederman is Board Certified in General and Child Psychiatry. He has been the recipient of the American Psychiatric Association Blanche Ittelson Award for Excellence in Child Psychiatric Research, the American Academy of Child and Adolescent Psychiatry Charlotte Norbert Rieger Award for Scientific Achievement. He has been inducted into the CHADD “Hall of Fame”. Dr Biederman has also been selected every year since its inception into the “The Best Doctors in America” compilation of the best physicians in the country. Dr Biederman has been a mentor to more than 15 junior investigators in the field. He is on the editorial board of multiple journals, a reviewer for most of the Psychiatric journals, and has served as a grant reviewer in the Child Psychopathology and Treatment Review Committee of the NIMH. Dr Biederman is the author and co-author of more than 500 scientific articles, 500 scientific abstracts, and 70 book chapters. In 2000, Dr Biederman pioneered and established a Stanley Foundation Center at the Massachusetts General Hospital dedicated to the treatment of pediatric bipolar disorder. Dr Biederman was the recipient of the 1998 NAMI Exemplary Psychiatrist award. He was also the recipient of the 2002 NARSAD Senior Investigator award. Since 2002 Dr Biederman has been Associate Editor and from 2005-2006 Deputy Editor for Child Psychiatry in Biological Psychiatry, ranked as the third most impactful scientific journal in Psychiatry. During the decade of the 1990’s, Dr Biederman was the fourth highest producer of high impact papers in psychiatry as determined by the Institute for Scientific Information and the highest rank child psychiatrist (Science, 2000, Vol 288, pg 959). A 2005 analysis by the same organization ) placed Dr Biederman as the second highest producer of high impact papers in psychiatry. The same organization ranked Dr Biederman at #1 in terms of total citations to his papers published on ADD/ADHD in the past decade—294 papers (meeting the search criteria), with a total of 6,866 cites. In 2005 Dr Biederman has been appointed as chair of the newly established section on ADHD at the World Psychiatric Association. Dr Biederman’s work is supported by multiple federal and pharmaceutical industry grants.
top
Peter S. Jensen, MD
Director, Center for the Advancement of Children’s Mental Health
Ruane Professor of Child Psychiatry
Columbia University College of Physicians and Surgeons New York, New York
Dr Peter S. Jensen is the Director of the Center for the Advancement of Children’s Mental Health—Putting Science to Work, and Ruane Professor of Child Psychiatry at the Columbia University College of Physicians and Surgeons, New York New York. Before coming to Columbia University, Dr Jensen was the Associate Director of Child and Adolescent Research at the National Institute of Mental Health (NIMH).
While at NIMH, he served as the lead NIMH investigator on the 6-site NIMH and Department of Education-funded study of Multimodal Treatment of Attention Deficit Hyperactivity Disorder (ADHD) the MTA study, and also as an investigator on other NIMH multi-site studies. At the Center, his major areas of work and research include the application of research findings into “real world” clinical settings and studies to encourage primary care practitioners and mental health specialists to apply optimal methods when working with children with ADHD, depression, and/or related conditions.
Dr Jensen currently serves on many editorial and scientific advisory boards, is the author of more than 200 scientific articles and book chapters, and has written or co-edited 13 books on children’s mental health. He has received numerous other national awards for his research, writing, and teaching.
top
James McCracken, MD
Professor and Director, Division of Child and Adolescent Psychiatry
University of California, Los Angeles (UCLA)
Dr James McCracken is the Joseph Campbell Professor and Director, Division of Child and Adolescent Psychiatry, at the University of California, Los Angeles (UCLA) Neuropsychiatric Institute and Hospital. He is a member of the Mental Retardation Research Center and is a senior research scientist in the Semel Institute for Human Behavior and Neuroscience at UCLA.
Dr McCracken is focusing current areas of research on the testing of new pharmacologic treatments for a variety of child neuropsychiatric disorders, including attention deficit hyperactivity disorder, autism, obsessive compulsive disorder, and anxiety disorders. He has been the principal investigator for more than 25 research grants. He has contributed to more than 150 publications in the area of child psychiatry and serves as Associate Editor for the Journal of Child and Adolescent Psychopharmacology and the Journal of Abnormal Child Psychology.
Dr McCracken received medical and postgraduate training at Baylor College of Medicine, Houston, Texas, Duke University, Durham, North Carolina, and UCLA before joining the faculty at UCLA in 1987. He is a member of the Tourette Syndrome National Medical Advisory Board. He is also the recipient of many distinguished honors and awards, including the 1992 American Psychiatric Association Young Psychiatrist Research Award, a Physician-Scientist Award from the National Institute of Mental Health (NIMH), and a Mid-Career Development Award from NIMH. He has been listed in Best Doctors in America since 1999 and is a fellow of the American Academy of Child and Adolescent Psychiatry and the American Psychiatric Association.
top
Thomas J. Spencer, MD
Associate Professor of Psychiatry, Harvard Medical School
Associate Chief, Clinical and Research Program in Pediatric Psychopharmacology
Massachusetts General Hospital Boston, Massachusetts
Thomas J. Spencer, MD, is Associate Professor of Psychiatry at Harvard Medical School and Associate Chief of the Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital, both in Boston, Massachusetts. Before joining Massachusetts General Hospital, he was Head of the Clinical Team for the Child and Adolescent Division of the Massachusetts Department of Mental Health.
Dr. Spencer’s research and clinical interests have focused on the effectiveness and safety of standard and novel pharmacologic treatments of attention-deficit/ hyperactivity disorder (ADHD) throughout the lifecycle. Dr. Spencer has been a co-investigator in Dr. Biederman’s longitudinal and family-genetic studies of ADHD. Dr. Spencer is the Principal Investigator in an NIMH funded project that examines the translation of improvement of ADHD symptoms into increased cognitive and functional capacities as well as quality of life in adults with ADHD. Dr. Spencer is also the Principal Investigator in a large, NIMH funded PET study examining dopamine transporter binding and genetic markers in Adults with ADHD. He also has edited a book on adult ADHD, published more than 170 scientific articles and over 35 book chapters and serves on the editorial boards of a number of journals.
top
Timothy E. Wilens, MD
Associate Professor of Psychiatry Harvard Medical School
Director of Substance Abuse Services Pediatric Psychopharmacology Clinic
Massachusetts General Hospital
Dr Timothy E. Wilens is Associate Professor of Psychiatry at Harvard Medical School, Boston, Massachusetts. In addition, he is Director of Substance Abuse Services in the Pediatric Psychopharmacology Clinic at Massachusetts General Hospital. Dr Wilens earned his medical degree at the University of Michigan Medical School, Ann Arbor. His residency in child, adolescent, and adult psychiatry was completed at Massachusetts General Hospital under the auspices of Harvard Medical School. He is triple board certified in adult, child/adolescent, and addiction psychiatry.
Dr Wilens’ research interests include the relationship among attention deficit hyperactivity disorder (ADHD), bipolar disorder, and substance abuse, and the pharmacotherapy of ADHD across the lifespan and juvenile bipolar disorder. His peer-reviewed articles concerning these and related topics number more than 170 and are published in prestigious journals such as JAMA, the American Journal of Psychiatry, Archives of General Psychiatry, and Pediatrics. He has also published more than 65 book chapters and 225 abstracts and presentations for national and international scientific meetings.
A Distinguished Fellow of the American Psychiatric Association and of the American Academy of Child and Adolescent Psychiatry, Dr Wilens is a scientific reviewer for 22 journals, as well as being active in a number of other local and national professional societies. He is named consistently among the Best of BostonChild/Adult Psychiatry and the Top/Best Doctors in America. top |
